Integrated Investment Consultants, LLC Abbott Laboratories Transaction History

Integrated Investment Consultants, LLC

$343 Million
Q2 2024

A detailed history of Integrated Investment Consultants, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Integrated Investment Consultants, LLC holds 8,130 shares of ABT stock, worth $964,218. This represents 0.25% of its overall portfolio holdings.

Number of Shares

8,130

Previous 8,130 -0.0%

Holding current value

$964,218

Previous $924,000 8.66%

% of portfolio

0.25%

Previous 0.27%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 18, 2024	SELL	$109.52 - $120.96 $55,636 - $61,447	-508 Reduced 5.88%	8,130 $924,000
Q4 2023 May 28, 2024	BUY	$90.19 - $110.4 $811 - $993	9 Added 0.11%	8,123 $894,000
Q4 2023 Jan 23, 2024	BUY	$90.19 - $110.4 $811 - $993	9 Added 0.1%	8,638 $950,000
Q3 2023 May 28, 2024	SELL	$95.53 - $114.62 $1,528 - $1,833	-16 Reduced 0.2%	8,114 $785,000
Q3 2023 Oct 17, 2023	SELL	$95.53 - $114.62 $19,965 - $23,955	-209 Reduced 2.36%	8,629 $835,000
Q2 2023 Jul 18, 2023	BUY	$100.78 - $112.29 $7,356 - $8,197	73 Added 0.83%	8,838 $963,000
Q1 2023 Jul 18, 2023	SELL	$96.86 - $114.01 $4,358 - $5,130	-45 Reduced 0.51%	8,793 $890,000
Q4 2022 Feb 13, 2023	BUY	$95.06 - $111.52 $45,913 - $53,864	483 Added 5.83%	8,765 $962,000
Q3 2022 Nov 21, 2022	BUY	$96.76 - $112.03 $19,545 - $22,630	202 Added 2.5%	8,282 $801,000
Q2 2022 Jul 19, 2022	SELL	$102.07 - $123.37 $69,101 - $83,521	-677 Reduced 7.73%	8,080 $878,000
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $79,243 - $96,632	-695 Reduced 7.35%	8,757 $1.04 Million
Q4 2021 Jan 10, 2022	SELL	$115.53 - $141.46 $157,813 - $193,234	-1,366 Reduced 12.63%	9,452 $1.33 Million
Q3 2021 Oct 28, 2021	BUY	$116.66 - $129.06 $1,516 - $1,677	13 Added 0.12%	10,818 $1.28 Million
Q2 2021 Jul 21, 2021	BUY	$105.79 - $124.53 $147,788 - $173,968	1,397 Added 14.85%	10,805 $1.25 Million
Q1 2021 Apr 20, 2021	SELL	$108.84 - $128.23 $130,281 - $153,491	-1,197 Reduced 11.29%	9,408 $1.13 Million
Q4 2020 Feb 09, 2021	SELL	$105.0 - $114.42 $23,100 - $25,172	-220 Reduced 2.03%	10,605 $1.16 Million
Q3 2020 Oct 26, 2020	SELL	$91.64 - $111.29 $4,582 - $5,564	-50 Reduced 0.46%	10,825 $1.18 Million
Q2 2020 Aug 04, 2020	SELL	$76.57 - $98.0 $8,575 - $10,976	-112 Reduced 1.02%	10,875 $994,000
Q1 2020 May 22, 2020	SELL	$62.82 - $91.86 $73,939 - $108,119	-1,177 Reduced 9.68%	10,987 $867,000
Q4 2019 Jan 29, 2020	SELL	$78.51 - $87.4 $21,747 - $24,209	-277 Reduced 2.23%	12,164 $1.06 Million
Q2 2019 Jul 16, 2019	BUY	$72.88 - $85.0 $25,508 - $29,750	350 Added 2.89%	12,441 $1.05 Million
Q1 2019 Apr 26, 2019	SELL	$66.22 - $80.06 $167,470 - $202,471	-2,529 Reduced 17.3%	12,091 $967,000
Q2 2018 Aug 09, 2018	SELL	$57.57 - $63.54 $1.89 Million - $2.09 Million	-32,870 Reduced 69.21%	14,620 $892,000
Q2 2018 Aug 01, 2018	BUY	$57.57 - $63.54 $1.89 Million - $2.09 Million	32,870 Added 224.83%	47,490 $925,000
Q1 2018 Apr 12, 2018	BUY	$56.27 - $63.62 $7,708 - $8,715	137 Added 0.95%	14,620 $876,000
Q3 2017 Oct 26, 2017	BUY	$48.06 - $53.64 $696,052 - $776,868	14,483	14,483 $773,000

Others Institutions Holding ABT

# of Institutions

3,167

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.19M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Integrated Investment Consultants, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integrated Investment Consultants, LLC with notifications on news.

Account

Integrated Investment Consultants, LLC Abbott Laboratories Transaction History